06/05/2026
At the Ivy Center, we're enrolling patients with newly diagnosed glioblastoma and recurrent high-grade glioma in a clinical trial targeting EGFR genetic alterations with the investigational therapy SILEVERTINIB (BDTX-1535).
Learn if your tumor has the specific biomarker by calling 602-406-8605 or visiting https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/current-trials/silevertinib-bdtx-1535-for-high-grade-glioma-and-glioblastoma/